Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 15, 2019 Off

New Research from Merck’s Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting

By BusinessWire

First-Time Data from POLO Trial Evaluating LYNPARZA® (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press…

May 15, 2019 Off

Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global Healthcare Conference

By BusinessWire

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer,…

May 15, 2019 Off

Second Sight Reports First Quarter 2019 Financial Results

By BusinessWire

— Company to Accelerate Development of Orion® Visual Cortical Prosthesis System — LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES)…

May 15, 2019 Off

AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

Published data in peer-reviewed scientific journal to advance potential cell therapy AgeX-BAT1 for Type II Diabetes and obesity Received $4.5…

May 15, 2019 Off

Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year

By BusinessWire

Cash, inclusive of merchant processor holdback, of $2.9 million as of May 13, 2019 SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma”…

May 15, 2019 Off

Apollo Endosurgery to Participate in Digestive Disease Week® 2019

By BusinessWire

AUSTIN, Texas–(BUSINESS WIRE)–Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric…

May 15, 2019 Off

Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia

By BusinessWire

– Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67 percent compared…

May 15, 2019 Off

Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia

By BusinessWire

– Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67 percent compared…

May 15, 2019 Off

Pharmaceutical Cartridges – Global Market to Reach $2.12 Billion in Value by 2026 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Cartridges – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. According to this report,…

May 15, 2019 Off

Scintomics and 1717 Life Science Ventures Team up in the Joint Venture PENTIXAPHARM to Develop CXCR4-Targeted Theranostics

By BusinessWire

Scintomics and 1717 LSV to collaborate in the development of novel cancer diagnostics and treatment BERLIN & MUNICH–(BUSINESS WIRE)–Scintomics GmbH…

Posts pagination

Previous 1 … 3,188 3,189 3,190 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine